Royal Bank Of Canada Nuvasive Inc Transaction History

Royal Bank Of Canada

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$36.71 - $44.15 $655,163 - $787,945	-17,847 Reduced 4.05%	422,972 $17.6 Million
Q1 2023 May 15, 2023	SELL	$36.81 - $48.12 $1.43 Million - $1.87 Million	-38,932 Reduced 8.12%	440,819 $18.2 Million
Q4 2022 Feb 14, 2023	SELL	$35.68 - $44.71 $1.76 Million - $2.21 Million	-49,453 Reduced 9.34%	479,751 $19.8 Million
Q3 2022 Nov 14, 2022	SELL	$42.51 - $54.02 $3.88 Million - $4.93 Million	-91,230 Reduced 14.7%	529,204 $23.2 Million
Q2 2022 Aug 15, 2022	SELL	$46.84 - $59.75 $1.89 Million - $2.41 Million	-40,271 Reduced 6.1%	620,434 $30.5 Million

Q1 2022 May 16, 2022	SELL	$48.09 - $57.79 $13.8 Million - $16.6 Million	-287,859 Reduced 30.35%	660,705 $37.5 Million
Q4 2021 Feb 14, 2022	SELL	$47.19 - $62.68 $3.78 Million - $5.02 Million	-80,012 Reduced 7.78%	948,564 $49.8 Million
Q3 2021 Nov 15, 2021	BUY	$56.91 - $67.81 $6.11 Million - $7.28 Million	107,350 Added 11.65%	1,028,576 $61.6 Million
Q2 2021 Aug 16, 2021	BUY	$64.02 - $71.72 $59 Million - $66.1 Million	921,226 New	921,226 $62.4 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.